Reduces muscle pain caused by cholesterol-lowering drugs
Called one of the “most vexing problems faced by cardiologists,” statin intolerance is a major concern for patients with high cardiovascular risk. For many, the associated muscle pain is unacceptable.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
However, there’s a new agent that may help reduce that statin side effect. Bempedoic acid is taken orally, once daily, in addition to cholesterol-lowering drugs.
In this video, learn more about why bempedoic acid is one of Cleveland Clinic’s Top 10 Medical Innovations for 2020.
Cleveland Clinic will offer rapid, pinpoint airborne transport of medications and other medical items
Dedicated committee and surgical fellowship strive for sustainability, energy efficiency, waste reduction
Next-generation mRNA vaccines are among the advancements likely to change healthcare this year
$50 million pledge will help remove sources of lead exposure from Cleveland homes
How to empower caregivers and engage patients in patient safety
Summit to cap off with Annual Top 10 Medical Innovations
The spine surgeon will oversee more than 125 staff physicians in his new role
Merlino rejoins Cleveland Clinic to help execute bold strategic vision